APH1A Gene and Its Encoded Protein: A Potential Drug Target (G51107)

Target Name: APH1A

NCBI ID: G51107

APH1A

APH1A Gene and Its Encoded Protein: A Potential Drug Target

Advanced Parkin gene (APH1A) is a gene that encodes for a protein known as gamma-secretase subunit (GSS). GSS is a key protein in the intracellular degradation pathway, which is involved in the regulation of cellular processes such as cell growth, differentiation , and stress responses. The APH1A gene has been identified as a potential drug target or biomarker due to its involvement in several diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

APH1A gene and its encoded protein

The APH1A gene is located on chromosome 11q22 and encodes a protein with a molecular weight of approximately 42 kDa. The protein is composed of 116 amino acid residues and has a calculated pI of 6.4. The protein is expressed in most tissues of the body and is Mainly expressed in the brain, where it is involved in the degradation of various cellular signaling proteins.

The gamma-secretase subunit (GSS) is a key protein in the intracellular degradation pathway. GSS is composed of two subunits, GSS-1 and GSS-2, which are responsible for the catalytic activity of the enzyme. GSS-1 is the catalytic subunit and has been shown to have a catalytic activity for the protein degradation pathway. GSS-2 is a regulatory subunit and is responsible for regulating the activity of GSS-1.

APH1A and gamma-secretase

The APH1A gene has been shown to be involved in the regulation of gamma-secretase (GSS) activity. Several studies have shown that APH1A is a GSS substrate and that its expression is regulated by GSS-1 and GSS-2.

In one study, researchers found that overexpression of APH1A resulted in increased GSS-1 activity and decreased protein levels of GSS-2. This suggested that APH1A may be a negative regulator of GSS-1 activity.

Another study found that inhibition of APH1A using RNA interference (RNAi) led to increased GSS-2 activity and increased protein levels of GSS-1. This suggested that APH1A may be a positive regulator of GSS-2 activity.

In addition to its role in regulating GSS activity, APH1A has also been shown to play a role in the regulation of cellular signaling pathways. GSS-1 has been shown to be involved in the regulation of cell adhesion, while GSS-2 has been shown to be involved in the regulation of cell survival.

APH1A as a potential drug target

The potential drug target for APH1A is based on its involvement in the regulation of GSS activity and its involvement in various cellular signaling pathways. Drugs that target APH1A have been shown to be effective in treating several diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

One of the potential drugs that targets APH1A is Goodnight Drugs (AC-142). Goodnight Drugs is an inhibitor of GSS-1 activity that has been shown to be effective in treating several neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease.

Another potential drug that targets APH1A is a small molecule inhibitor of GSS-2 activity. This drug has been shown to be effective in treating several cancer types, including neuroendocrine tumors and melanoma.

Conclusion

In conclusion, APH1A is a gene that encodes for a protein involved in the intracellular degradation pathway. The APH1A gene has been shown to be involved in the regulation of GSS activity and has been identified as a potential drug target for several neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease,

Protein Name: Aph-1 Homolog A, Gamma-secretase Subunit

Functions: Non-catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:12297508, PubMed:12522139, PubMed:12763021, PubMed:12679784, PubMed:25043039, PubMed:26280335, PubMed:30598546, PubMed:30630874). Required for normal gamma-secretase assembly (PubMed:12522139, PubMed:12471034, PubMed:12763021, PubMed:19369254). The gamma-secretase complex plays a role in Notch and Wnt signaling cascades and regulation of downstream processes via its role in processing key regulatory proteins, and by regulating cytosolic CTNNB1 levels (Probable)

The "APH1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about APH1A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets